Mass General Brigham, Inc

SEC CIK: 0001678378
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

JNCE holding history

Jounce Therapeutics, Inc. in every 13F filed by Mass General Brigham, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JNCE overview All 13F holders of JNCE Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of JNCE by Mass General Brigham, Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−20,957−100.0%	Sold out	Holders
Q1 2022	20,957	$1.00K	<0.1%	+20,957	New	Holders
Q3 2021	0	$0	0.0%	−19,291−100.0%	Sold out	Holders
Q2 2021	19,291	$131.0K	<0.1%	+19,291	New	Holders